Ceribell vs KATE
Neurology, ICU and emergency teams are Ceribell's buyers, and emergency department nursing leaders are KATE's. Ceribell's point-of-care EEG gives seizure alerts, and the vendor says its seizure detection covers 25-week preterm infants through adults. KATE gives emergency nurses a triage acuity recommendation and a sepsis risk flag from EHR data.
Ceribell has 16 FDA 510(k) records, among them the Delirium Monitor System cleared on December 8, 2025. For KATE, the FDA item is a Breakthrough Device Designation for KATE Sepsis announced on November 14, 2023, which is a designation and not a clearance. openFDA lists no record under Mednition.
Ceribell's homepage and Clarity page name no EHR, and Mednition's homepage says only that KATE fits an "existing workflow and EMR". Mednition's evidence is a 2019 vendor study claiming triage accuracy up 26.9%, still in peer review when announced, and three PubMed papers by Mednition-employed authors whose product is not named.
Decision support · Reviewed November 2, 2026
When to pick each one
Ceribell
- Sixteen FDA 510(k) records, delirium monitor cleared December 2025
- Bedside EEG with seizure alerts for suspected status epilepticus
KATE
- ED triage acuity and sepsis flag from EHR data
- Breakthrough designation for KATE Sepsis, not a clearance
Score
Each row shows points earned of points available under the published rubric.
Ceribell
49of 100
KATE
12of 100
| Dimension | Ceribell | KATE | Difference |
|---|---|---|---|
| FDA clearance | 12 / 12 | 0 / 12 | +12 |
| HIPAA / SOC2 / BAA | 0 / 10 | 0 / 10 | 0 |
| EHR integrations (count) | 0 / 5.6 | 0 / 5.6 | 0 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 4.8 | 0 / 4.8 | 0 |
| Bidirectional write-back | 0 / 1.2 | 0 / 1.2 | 0 |
| Peer-reviewed papers | 14.7 / 21 | 0 / 21 | +14.7 |
| RCT / meta-analysis / systematic review | 4.5 / 9 | 0 / 9 | +4.5 |
| Funding & adoption signal | 8.4 / 12 | 3 / 12 | +5.4 |
| Pricing transparency | 1.3 / 2.5 | 1.3 / 2.5 | 0 |
| Years in market | 0 / 6 | 6 / 6 | -6 |
Scroll horizontally to see every column.
Pricing
Ceribell
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. Purchase terms: one-year initial term, auto-renewing yearly unless 90 days notice. |
KATE
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Evidence
Ceribell
FDA decisions
K261712 (opens in new tab)510(k)2026-09-16
Ceribell EEG Analysis Software
K261101 (opens in new tab)510(k)2026-06-30
Ceribell Monitor
K260998 (opens in new tab)510(k)2026-06-24
Ceribell Neurology Review Software
K260363 (opens in new tab)510(k)2026-04-03
Ceribell Brain Monitor Headband
K254033 (opens in new tab)510(k)2026-02-09
Ceribell Instant EEG Headset
Show 11 more
K251936 (opens in new tab)510(k)2025-12-08
Ceribell Delirium Monitor System
K252070 (opens in new tab)510(k)2025-11-21
Ceribell Infant Seizure Detection Software
K251381 (opens in new tab)510(k)2025-10-31
Ceribell Instant EEG Headcap
K241589 (opens in new tab)510(k)2025-04-09
Ceribell Seizure Detection Software
K232052 (opens in new tab)510(k)2023-08-08
Ceribell Instant EEG Headband
K223504 (opens in new tab)510(k)2023-05-23
Ceribell Status Epilepticus Monitor
K223086 (opens in new tab)510(k)2023-03-22
Ceribell Instant EEG Headcap
K210805 (opens in new tab)510(k)2021-08-30
Ceribell Instant EEG Headband
K191301 (opens in new tab)510(k)2019-09-11
Ceribell Pocket EEG Device
K171459 (opens in new tab)510(k)2017-08-21
Ceribell Instant EEG Headband
K170363 (opens in new tab)510(k)2017-05-08
Ceribell Pocket EEG Device
Peer-reviewed
4 PubMed records name Ceribell.
- Automated Seizure Detection in Patients with Cardiac Arrest: A Retrospective Review of Ceribell™ Rapid-EEG Recordings. (opens in new tab)
- Point-of-Care EEG Artificial Intelligence Measure of Seizure Burden Associates With Clinical Outcome at Discharge. (opens in new tab)
- Assessing the performance of artificial intelligence in detecting electrographic status epilepticus when human experts often disagree. (opens in new tab)
KATE
FDA decisions
No FDA decision cited in our research as of November 2, 2026.
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Ceribell | KATE |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Not specified |
| Founded | n/a | 2014 |
| HQ | US | US |
Scroll horizontally to see both columns.
Common questions
Open the full decision support comparison
Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.